Deborah Tapp, NP
Nurse Practitioner · Evansville, INNPI 1194206789
Payments from drug & device makers
Across 16 payments — averaging $17.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$117
- Abbott$69
- Lundbeck LLC$20
- Tersera Therapeutics LLC$18
- Scilex Pharmaceuticals Inc.$17
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$17
- plus $15 from 1 others
What the payments were for
- Food & beverage$272100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 7 | $117 |
| Abbott | 4 | $69 |
| Lundbeck LLC | 1 | $20 |
| Tersera Therapeutics LLC | 1 | $18 |
| Scilex Pharmaceuticals Inc. | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Masimo Corporation | 1 | $15 |
How this compares
$272 in reported general payments places this provider in the 55th percentile of 2,724 nurse practitioner providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 23 | $18,117 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 548 | $13,810 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 510 | $13,198 |
| OxycontinOxycodone Hcl | 17 | $12,384 |
| MovantikNaloxegol Oxalate | 13 | $7,701 |
| Xtampza ErOxycodone Myristate | 12 | $7,294 |
| Fentanyl | 28 | $5,490 |
| Buprenorphine | 16 | $4,639 |
| Pentazocine-Naloxone HclPentazocine Hcl/Naloxone Hcl | 26 | $3,409 |
| Gabapentin | 248 | $2,678 |
| Oxycodone Hcl | 100 | $2,429 |
| Pregabalin | 83 | $2,216 |
| Hydromorphone Hcl | 44 | $1,766 |
| Lidocaine | 26 | $1,721 |
| Morphine Sulfate ErMorphine Sulfate | 35 | $1,389 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Evansville
- Stacey RickettsEvansville$18K
- Helen EvansEvansville$9K
- Kirk AshburnEvansville$9K
- Zhuang SantacanaEvansville$9K
- Brittney PhippsEvansville$9K
- Kristi OrbaughIndianapolis$1.3M
- Kimberly EadsPlainfield$302K
- Sean GoddardFort Wayne$180K
- Kacy RogersIndianapolis$77K
- Kristine TaylorFort Wayne$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.